Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medicines Co (NASDAQ:MDCO)

50.69
Delayed Data
As of Mar 24
 +0.70 / +1.40%
Today’s Change
29.48
Today|||52-Week Range
55.28
+49.35%
Year-to-Date
Alnylam's LDL-Lowering Drug Positive in Phase II Study
Mar 20 / Zacks.com - Paid Partner Content
Trump, Biogen and Amgen Hammer Healthcare ETFs
Mar 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close49.99
Today’s open50.10
Day’s range49.69 - 50.94
Volume1,172,089
Average volume (3 months)1,672,521
Market cap$3.6B
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+67.46%
Earnings growth (this year)-203.92%
Earnings growth (next 5 years)+72.90%
Revenue growth (last year)-45.69%
P/E ratioNM
Price/Sales14.14
Price/Book5.52

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...-0.11-1.01%
CTLTCatalent Inc+0.06+0.21%
PTHNPatheon NV-0.23-0.87%
GLPGGalapagos NV+1.73+2.15%
Data as of 4:04pm ET, 03/24/2017

Financials

Next reporting dateApril 26, 2017
EPS forecast (this quarter)-$1.29
Annual revenue (last year)$167.8M
Annual profit (last year)-$120.1M
Net profit margin-71.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Clive A. Meanwell
President &
Chief Operating Officer
Tony Kingsley
Corporate headquarters
Parsippany, New Jersey

Forecasts


Search for Jobs